Workflow
盟科药业(688373) - 2023 Q3 - 季度财报
MicuRxMicuRx(SH:688373)2023-10-26 16:00

Financial Performance - The company's revenue for Q3 2023 reached ¥26,162,143.66, representing an increase of 80.76% year-over-year[5] - The net loss attributable to shareholders for Q3 2023 was ¥119,336,002.30, with a cumulative loss of ¥244,458,619.10 for the year-to-date[5] - The basic and diluted earnings per share for Q3 2023 were both -¥0.18, with a year-to-date figure of -¥0.37[6] - The company's revenue for the year-to-date increased by 95.87% compared to the same period last year, driven by expanded sales channels and increased hospital coverage[10] - Total revenue for the first three quarters of 2023 reached ¥68,272,315.43, a significant increase of 96.0% compared to ¥34,856,252.61 in the same period of 2022[23] - The net loss for the first three quarters of 2023 was ¥244,458,619.10, compared to a net loss of ¥173,774,505.72 in the same period last year[24] - The basic and diluted earnings per share for the first three quarters of 2023 were both -¥0.37, compared to -¥0.31 in the same period of 2022[25] - The company reported a comprehensive loss of ¥233,615,904.71 for the first three quarters of 2023, compared to a comprehensive loss of ¥167,888,245.71 in the previous year[25] Research and Development - Research and development expenses totaled ¥106,851,465.54 in Q3 2023, accounting for 408.42% of revenue, an increase of 67.16 percentage points compared to the previous year[6] - The R&D investment for the year-to-date was ¥202,949,875.30, reflecting a 76.57% increase compared to the previous year[6] - Research and development expenses surged to ¥202,949,875.30, representing an increase of 76.3% from ¥114,940,211.45 in the first three quarters of 2022[23] - The company experienced a significant increase in R&D team size and clinical progress of projects, contributing to the rise in operational costs[10] Assets and Liabilities - The total assets at the end of Q3 2023 were ¥1,280,831,919.59, a decrease of 14.46% from the end of the previous year[6] - As of September 30, 2023, the total current assets amounted to RMB 1,163,559,404.99, a decrease of 15.1% from RMB 1,370,505,453.28 at the end of 2022[16] - The total assets decreased to RMB 1,280,831,919.59 from RMB 1,497,370,060.54, indicating a decline of 14.5%[18] - The total non-current assets decreased to RMB 117,272,514.60 from RMB 126,864,607.26, a decline of 7.5%[18] - The total liabilities decreased to RMB 1,280,831,919.59, down from RMB 1,497,370,060.54, reflecting a decrease of 14.5%[18] - The total liabilities as of the end of the third quarter of 2023 were ¥273,393,988.31, a slight decrease from ¥283,095,971.09 at the end of the previous year[19] - The total equity attributable to shareholders decreased to ¥1,007,437,931.28 from ¥1,214,274,089.45 year-over-year[19] Cash Flow - The company reported a cash flow from operating activities of -¥224,781,414.57 for the year-to-date[6] - The net cash flow from operating activities was -224,781,414.57, compared to -178,919,707.70 in the previous year, indicating a decline in operational cash flow[28] - The company reported a total cash outflow from operating activities of 310,838,619.02, compared to 225,979,395.42 in the previous year[28] - Total cash inflow from investment activities reached 3,002,899,520.59, significantly higher than 842,619,850.23 in the same period last year[28] - The net cash flow from investment activities was 263,135,168.83, a recovery from -581,605,693.99 in the previous year[28] - Cash inflow from financing activities totaled 60,000,000.00, down from 1,008,616,000.00 in the previous year[29] - The net cash flow from financing activities was -8,381,107.62, contrasting with a positive 962,047,986.64 in the same period last year[29] - The total cash and cash equivalents at the end of the period amounted to 179,156,080.20, compared to 298,400,960.61 at the end of the previous year[29] Shareholder Information - The company reported a significant increase in the number of shareholders, with the top 10 shareholders holding a total of 10.92% to 10.49% of shares each[15] - The company has not engaged in any financing or margin trading activities as of the report date[15] Operational Costs - Total operating costs for the first three quarters of 2023 amounted to ¥335,652,567.97, up 49.7% from ¥224,307,692.69 in the previous year[23] - Cash paid for purchasing goods and services was 213,235,007.86, up from 147,875,569.11 in the same period last year[28] - Cash paid to employees increased to 79,034,179.00 from 68,822,056.38 in the previous year[28]